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The Influence of Taxation of the Financial-Economic Performances 
of the Companies in the Pharmaceutical Field 
 
Abstract: In order to determine the impact taxation has on the financial-economic performances, we 
must strongly consider the determination relations of the financial performance indexes based on the 
profit and loss account. Aiming at appreciating the alternative of the commercial policy promoted by 
the company, it is mandatory to decompose the produced commercial margin or to emphasize it on 
fields of activity, as the margin variation also depends on the rotation of stocks. The lowering of the 
commercial margin must be balanced through an increase in the sales, which leads to the reorientation 
of the commercial policy. 
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1. Introduction 
The method through which taxation influences the performances of the company 
through this indicator is noticed when calculating the indicator by summing up the 
following elements: The unemployment fund, the salaries fund and the contribution 
to social insurance funds, special funds (workforce remuneration); Taxes and fees 
(external factor that cannot be controlled by trading companies); Profit expressed 
through monetary units; Depreciation (the value of the capital assets extended over 
the realized production). 
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2. The Influence of Taxation on the Financial Decisions of the Company 
The financial-economic activity of one company must be organized, constituted on 
the basis of an optimal action line, from more possible variants, by 
adopting/implementing of a financial decision. Financial decisions adopted by the 
management of a trading company can be classified in: investment decision, 
financing decision, and the decision on profit distribution. The influence of taxation, 
through the dimension of taxes and fees that are owed and paid by investors is 
especially manifested at the level of the treasury through the diminishing liquidity 
availability. Economic agents approach a taxation strategy by using some specific 
instruments and techniques in order to gain some taxation advantages. The leading 
stuff of a trading company must pursue the harmonization of the taxation policy and 
their own development strategy. An efficient taxation management is made by 
managing the taxation issues such that the legal provisions in the field to be 
respected, registering a low level of tax burden, thus diminishing the taxation risk. 
 
3. The Analysis of the Financial Position and of the Stability of the 
Company under the Influence of Taxation 
The evaluation of the performance of one company is made by analyzing the 
financial and economic effects of the management decisions regarding the 
operations, investments and the financing of the company. For an accurate image of 
the financial position and of the stability of one commercial company, we must 
consider the efficient use of the resources the company has, the prudential and 
correct adoption of the financing decisions and if the profitability of the company 
reaches the foreseen level. For their internal analysis, companies use a series of 
indicators which reflect the impact the decisions have on the performance and the 
stability of the company. 
 
4. Pharmaceutical Industry in Romania 
Pharmaceutical industry represents, at a global level, one of the most developed 
industry that currently concentrates the highest value of investments. Medication 
plays a basic role for the health status of population, and the access to it means the 
appreciation of human health through the guaranty given to the population of 
benefiting from the technological discoveries and the scientific innovations in this 
field. 
Pharmaceutical research is mostly attributed to the nationally and internationally 
developed drugstores. Due to the fact that the pharmaceutical industry is privatized, 
made researches and the criteria on which this pharmaceutical market functions are 
oriented by the demand and the offer located at national or global level. 
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Most of the investments and resources accumulations are located at the level of the 
neurological and psychic, cardiovascular diseases and different types of cancer. This 
trend is reflected by most of the countries, developed or poor ones. At global level, 
within the researches made in the pharmaceutical industry, one has noticed the 
significance given to a market segment, namely for the products designed to reduce 
cellulite, wrinkles or fighting stress, which presents high interest especially for reach 
countries. 
This reorientation of the pharmaceutical industry which has also generated a division 
between countries depending on their preference of investing, might be the result of 
the followings: 
 The costs and the risk related to these investments, as the purchasing power in 
the less developed countries is low, and the depreciation period of the investment is 
long. Due to this fact, one prefers investing in developed countries for products that 
do not imply many risks; 
 The competition of fake medicine that copies the quality medicine in developed 
countries and uses, as marketplaces, the markets in the less developed countries 
where the legislation is deficient; 
 The costs related to the quality standards which have mandated the drugstores to 
meet certain regulations which have increased the development costs. 
Underdeveloped countries that do not have sufficient financial and technological 
resources are now dominated by developed countries. 
 
5. Pharmaceutical Market in Romania 
The pharmaceutical industry in Romania has reported significant evolutions in time, 
but many of these evolutions have not been enough studied regarding their 
consequences on the economic environment in Romania. Many of the significant 
scientific researches and the investments made in this field have not been sufficiently 
documented. 
The pharmaceutical market in Romania currently represents one of the most goods 
and services providers in the public sector. This industry though has to face obstacles 
resulting from the deficient financial situation in the public sector. The collection 
period of liabilities by the pharmaceutical producers from the economic sector can 
overpass 300 days. These delays have dramatic consequences on the whole 
pharmaceutical industry, which has been transformed into one of the largest creditors 
of the Romanian Government. 
The activity carried out on the pharmaceutical products’ market is inferior to the 
corporate sector in Romania due to the fact that pharmacies do not consider bank 
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loans as a financing source, but the stakeholders. The pharmaceutical industry is not 
facing the risk of returning its financial liabilities, reporting a ratio of non-performing 
credits which is significantly lower than the average of the Romanian economy. 
The evolution registered at the level of the pharmaceutical market has also been 
positive and increasing even during the years when the Romanian economy faced 
crisis. The pharmaceutical industry in Romania is one of the fields that reported 
increases in exports over the national average. Many companies displayed a special 
interest for the increasing of the exports but they did not reflected a quantitative 
program figured by the labor productivity and added value. 
The pharmaceutical market generates the largest taxation and fee contributors in 
Romania. The contributions included in medicine and pharmaceutical products (fees, 
added value tax, excise duties) represent 1,14% of the total taxes on collected 
products owed to the state budget. The pharmaceutical industry represents one of the 
most important employers of the Romanian economic environment. 
From the taxation perspective, the health system in Romania suffers due to the aging 
population which modifies the contributors’ number and magnitude. The large 
segment of aging population though contributes to the high demand for medication 
and pharmaceutical products. We foresee that the percentage of the population over 
50 years old will go from 36% (2015) to 43% in 2020. 
 
Figure 1. The prognosis of demographic data in Romania 2015-2020  
Romania reflects an average life expectancy under the European average. In 
developed countries in Europe, such as Germany, Italy or Great Britain, the average 
life expectancy of women is more than 83 years and the one of men is approximately 
71 years. Subsequently to the carried out analyses and statistics, generated data 
indicates that Romania is also located under the European average from the 
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education and prevention in the health system has generated a Romanian population 
spending many time in morbidity and disability, exactly 13 years in the case of men 
and 21 in the case of women. 
 
6. Particularities of the Pharmaceutical Products Consumption 
Romania is located above the European average regarding the breaking of 
prescription drugs or OTC with a percentage of 76% from the total volume of 
medication consumed in 2014, compared to the European average of 64%. 
Innovative medication represents the highest percentage from the perspective of 
value from the total consumption of medication, namely 60%. The highest 
investments in this field were made by the producers on innovative medication, 
which invested 33,1 mil EUR in clinical studies for the population in Romania. 
 
Figure 2  
Source: Personal processing based on the study of PricewaterhouseCoopers Tax Advisors 
& Accountants S.R.L. (PwC) 
In order to encourage the innovation on the pharmaceutical products’ market in 
Romania, in 2014 investments were made in clinical studies that aimed 
hematological affections (the highest percentage), oncology diseases and infectious 
ones. Pharmaceutical companies specialized in the production of medicine have 
organized approximately 110 prevention and informing programs. 
A significant segment of the pharmaceutical industry is represented by the activity 
of the medication distributors. Medicine, pharmaceutical products, before being 
distributed, must be authorized by the National Agency of Medication. During the 
last years, it has reported a performance from the perspective of reached results, as 
the pharmaceutical products retail due to the increase in the medication demand and 
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The activity within the pharmaceutical industry, both the one of the medication 
producers and the one of the distributors, generates contributions owed to the state 
budget. A significant part of the medication producers’ contributions to the GDP is 
represented by the tax and fees that are paid to the state budget. 
Table 1. Contributions to the Romanian budget, 2015-2017 (mil RON) 
CONTRIBUTION TYPE 2015 2016 2017 
TAXES AND FEES Income tax 77 104,72 81,4 
Others  (propriety tax, custom duties, excise 
duties) 
3,52 6,6 7,04 
Total taxes and fees 80,52 111,76 88,44 
FIELD RELATED 
PAYMENTS 
 „clowback” tax 766,92 1.056,44 1.074,04 
Other specific payments 16,20 20,24 109,56 




Employee contributions 99,88 99 101,2 
Employer contributions  90,64 84,92 85,00 
Total social insurances contributions  190,52 183,92 186,2 
Total contribution to the state budget 1.054,16 1.372,36 1.458,24 
The contribution of medication producers was approximated at 75% of the 
“clawback” tax in 2017. This type of tax has reported increases due to the growth of 
the compensated medication consumption and of the unchanged budget, so that this 
tax grew from 10,4% of the turnover in 2015 to 14,8% in 2016. In 2017 clawback 
tax reached 17,2%. 
 
Conclusions 
The taxation system in Romania does not only consider the macro-economic level. 
Managers of trading companies which elaborate an efficient taxation management 
use legal means and instruments which allow the reaching of taxation advantages. 
The influence of the tax burden is made towards the direct taxation and it is most 
frequently noticed through the corporate tax that companies owe to the state budget. 
Most of the taxation decisions approached by the political factors in order to support 
the financial resources needed by the public needs generate the taxation policy. We 
can thus assume that the taxation policy represents the multitude of decisions which 
structure the taxation system and which ensure its efficient functioning. Mandatory 
payments stipulated in regulation documents are the types of taxes, fees or related 
payments and aim at the revenues of companies or individuals. 
In order for the economic agents to be able to develop their activity, the 
implementation of an optimal taxation management system is needed, which would 
ensure the meeting of the legal requirements in the field, so that to lower the taxation 
risk and the level of the tax burden. 
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